EUVIMEDEUVIMED entdecken
Open Access

Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Boqun Shi iD, Hao-Yu Wang iD, Jinpeng Liu, Zhongxing Cai, Chenxi Song, Dong Yin, Hongjian Wang iD, Qiuting Dong, Weihua Song iD, Ke-Fei Dou iD

Journal of the American Heart Association · 04.04.2023 · 12 (7)

DOI: 10.1161/jaha.122.025812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 04.04.2023. Verfasst von Boqun Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital Chinese Academy of Medical Sciences & Peking Union Medical College/National…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The PRAISE (Prediction of Adverse Events Following an Acute Coronary Syndrome) score is a machine‐learning‐based model for predicting 1‐year all‐cause death, myocardial infarction, and Bleeding Academic Research Consortium (BARC) type 3/5 bleeding. Its utility in an unselected Asian population undergoing percutaneous coronary intervention for acute coronary syndrome remains unknown. We aimed to validate the PRAISE score in a real‐world Asian population. Methods and Results A total of 6412 consecutive patients undergoing percutaneous coronary intervention for acute coronary syndrome were prospectively included. The PRAISE scores were compared with established scoring systems (GRACE [Global Registry of Acute Coronary Events] 2.0, PRECISE‐DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy), and PARIS [Patterns of Non‐Adherence to Anti‐Platelet Regimen in Stented Patients]) to evaluate their discrimination, calibration, and reclassification. The risk of all‐cause mortality (hazard ratio [HR], 12.24 [95% CI, 5.32–28.15]) and recurrent acute myocardial infarction (HR, 3.92 [95% CI, 1.76–8.73]) was greater in the high‐risk group than in the low‐risk group. The C‐statistics for death, myocardial infarction, and major bleeding were 0.75 (0.67–0.83), 0.61 (0.52–0.69), and 0.62 (0.46–0.77), respectively. The observed to expected ratio of death, myocardial infarction, and major bleeding was 0.427, 0.260, and 0.106, respectively. Based on the decision curve analysis, the PRAISE score displayed a slightly greater net benefit for the 1‐year risk of death (5%–10%) than the GRACE score did.

Conclusions

The PRAISE score showed limited potential for risk prediction in our validation cohort with acute coronary syndrome. As a result, new prediction models or model refitting are required with improved discrimination and accuracy in risk prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeMyocardial InfarctionPercutaneous Coronary InterventionHumansPlatelet Aggregation InhibitorsPrognosisRisk AssessmentTreatment OutcomeDrug Therapy, CombinationHemorrhageIschemia

Stichwörter der Autor:innen

PRAISE scoreacute coronary syndromemachine learningrisk stratification

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases Beijing China.
  • Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases Beijing China.
  • State Key Laboratory of Cardiovascular Disease Beijing China.
  • National Clinical Research Center for Cardiovascular Diseases Beijing China.

ORCID-Profile: Boqun Shi, Hao-Yu Wang, Hongjian Wang, Weihua Song, Ke-Fei Dou

Zitieren

APA

Shi, B., Wang, H. Y., Liu, J., Cai, Z., Song, C., Yin, D., Wang, H., Dong, Q., Song, W., & Dou, K. F. (2023). Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association, 12(7). https://doi.org/10.1161/jaha.122.025812

Vancouver

Shi B, Wang HY, Liu J, Cai Z, Song C, Yin D, et al. Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association. 2023;12(7). doi:10.1161/jaha.122.025812

BibTeX
@article{Shi2023,
  author = {Shi, Boqun and Wang, Hao-Yu and Liu, Jinpeng and Cai, Zhongxing and Song, Chenxi and Yin, Dong and Wang, Hongjian and Dong, Qiuting and Song, Weihua and Dou, Ke-Fei},
  title = {Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {7},
  doi = {10.1161/jaha.122.025812}
}
Kostenlos starten →